Anogenital distribution of mucosal HPV in males and females before and after renal transplantation.

Anus Cervix Papillomavirus Penis Renal transplant

Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
09 Nov 2023
Historique:
received: 30 06 2023
revised: 18 10 2023
accepted: 06 11 2023
pubmed: 11 11 2023
medline: 11 11 2023
entrez: 10 11 2023
Statut: aheadofprint

Résumé

Immunosuppressive drugs taken by transplant recipients may favor HPV infection at anogenital sites. HPV-type prevalence was studied in males and females before and after renal transplantation. Anal, cervical and penile samples were taken from 62 patients before transplantation and from 41 patients after transplantation. HPV DNA was investigated using the INNO-LiPA HPV genotyping extra test and HPV-type distribution determined. Before transplantation, up to 30% of analyzed samples harbored HPV DNA, with the highest prevalence found in cervical specimens (60%). After transplantation, a trend toward HPV clearance was observed in females. By contrast, a trend toward incident infections by a wide variety of HPV genotypes at the penis and anal level was documented in men. High prevalence of HPV at anogenital sites was documented before and after renal transplantation. Immunosuppressive drugs taken after transplantation may impact HPV acquisition or reactivation, especially in males. Special attention should be paid in view of preventing HPV-associated diseases in this vulnerable population.

Identifiants

pubmed: 37949172
pii: S2666-9919(23)00192-6
doi: 10.1016/j.idnow.2023.104830
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104830

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jean-Luc Prétet (JL)

Université de Franche-Comté, Carcinogenèse associée aux HPV, F-25000, Besançon, France; CHU Besançon, Centre National de Référence Papillomavirus, F-25000, Besançon, France; CHU Besançon, CIC1431, F-25000, Besançon, France. Electronic address: jean_luc.pretet@univ-fcomte.fr.

Antoine Touzé (A)

UMR INRA ISP 1282, Équipe Biologie des infections à polyomavirus, Université de Tours, Tours, France.

Lionel Pazart (L)

CHU Besançon, CIC1431, F-25000, Besançon, France.

Guillaume Boiteux (G)

CHU Besançon, CIC1431, F-25000, Besançon, France.

Véronique Fournier (V)

Hôpital Nord Franche-Comté, F-90400, Trevenans, France.

Chrystelle Vidal (C)

CHU Besançon, CIC1431, F-25000, Besançon, France.

Françoise Arnold (F)

UMR INRA ISP 1282, Équipe Biologie des infections à polyomavirus, Université de Tours, Tours, France.

Didier Ducloux (D)

Université de Franche-Comté, EFS, INSERM, inst RIGHT, F-25000, Besançon, France.

Quentin Lepiller (Q)

Université de Franche-Comté, Carcinogenèse associée aux HPV, F-25000, Besançon, France; CHU Besançon, Centre National de Référence Papillomavirus, F-25000, Besançon, France.

Christiane Mougin (C)

CHU Besançon, Centre National de Référence Papillomavirus, F-25000, Besançon, France; Université de Franche-Comté, EFS, INSERM, inst RIGHT, F-25000, Besançon, France.

Classifications MeSH